BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

451 related articles for article (PubMed ID: 34550771)

  • 1. Semi-continuous Propagation of Influenza A Virus and Its Defective Interfering Particles: Analyzing the Dynamic Competition To Select Candidates for Antiviral Therapy.
    Pelz L; Rüdiger D; Dogra T; Alnaji FG; Genzel Y; Brooke CB; Kupke SY; Reichl U
    J Virol; 2021 Nov; 95(24):e0117421. PubMed ID: 34550771
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiscale model of defective interfering particle replication for influenza A virus infection in animal cell culture.
    Rüdiger D; Pelz L; Hein MD; Kupke SY; Reichl U
    PLoS Comput Biol; 2021 Sep; 17(9):e1009357. PubMed ID: 34491996
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cell culture-based production and in vivo characterization of purely clonal defective interfering influenza virus particles.
    Hein MD; Arora P; Marichal-Gallardo P; Winkler M; Genzel Y; Pöhlmann S; Schughart K; Kupke SY; Reichl U
    BMC Biol; 2021 May; 19(1):91. PubMed ID: 33941189
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Novel Type of Influenza A Virus-Derived Defective Interfering Particle with Nucleotide Substitutions in Its Genome.
    Kupke SY; Riedel D; Frensing T; Zmora P; Reichl U
    J Virol; 2019 Feb; 93(4):. PubMed ID: 30463972
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence that two instead of one defective interfering RNA in influenza A virus-derived defective interfering particles (DIPs) does not enhance antiviral activity.
    Bdeir N; Arora P; Gärtner S; Pöhlmann S; Winkler M
    Sci Rep; 2021 Oct; 11(1):20477. PubMed ID: 34650149
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiviral Activity of Influenza A Virus Defective Interfering Particles against SARS-CoV-2 Replication In Vitro through Stimulation of Innate Immunity.
    Rand U; Kupke SY; Shkarlet H; Hein MD; Hirsch T; Marichal-Gallardo P; Cicin-Sain L; Reichl U; Bruder D
    Cells; 2021 Jul; 10(7):. PubMed ID: 34359926
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Single-Cell Analysis Uncovers a Vast Diversity in Intracellular Viral Defective Interfering RNA Content Affecting the Large Cell-to-Cell Heterogeneity in Influenza A Virus Replication.
    Kupke SY; Ly LH; Börno ST; Ruff A; Timmermann B; Vingron M; Haas S; Reichl U
    Viruses; 2020 Jan; 12(1):. PubMed ID: 31936115
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cell culture-based production of defective interfering particles for influenza antiviral therapy.
    Wasik MA; Eichwald L; Genzel Y; Reichl U
    Appl Microbiol Biotechnol; 2018 Feb; 102(3):1167-1177. PubMed ID: 29204901
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modeling the intracellular replication of influenza A virus in the presence of defective interfering RNAs.
    Laske T; Heldt FS; Hoffmann H; Frensing T; Reichl U
    Virus Res; 2016 Feb; 213():90-99. PubMed ID: 26592173
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Generation of "OP7 chimera" defective interfering influenza A particle preparations free of infectious virus that show antiviral efficacy in mice.
    Dogra T; Pelz L; Boehme JD; Kuechler J; Kershaw O; Marichal-Gallardo P; Baelkner M; Hein MD; Gruber AD; Benndorf D; Genzel Y; Bruder D; Kupke SY; Reichl U
    Sci Rep; 2023 Nov; 13(1):20936. PubMed ID: 38017026
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of Ongoing Influenza A Virus Replication Reveals Different Mechanisms of RIG-I Activation.
    Liu G; Lu Y; Liu Q; Zhou Y
    J Virol; 2019 Mar; 93(6):. PubMed ID: 30602605
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of defective interfering particles on virus replication and antiviral host response in cell culture-based influenza vaccine production.
    Frensing T; Pflugmacher A; Bachmann M; Peschel B; Reichl U
    Appl Microbiol Biotechnol; 2014 Nov; 98(21):8999-9008. PubMed ID: 25132064
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Broad-Spectrum Antiviral Activity of Influenza A Defective Interfering Particles against Respiratory Syncytial, Yellow Fever, and Zika Virus Replication In Vitro.
    Pelz L; Piagnani E; Marsall P; Wynserski N; Hein MD; Marichal-Gallardo P; Kupke SY; Reichl U
    Viruses; 2023 Sep; 15(9):. PubMed ID: 37766278
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A system for production of defective interfering particles in the absence of infectious influenza A virus.
    Bdeir N; Arora P; Gärtner S; Hoffmann M; Reichl U; Pöhlmann S; Winkler M
    PLoS One; 2019; 14(3):e0212757. PubMed ID: 30822349
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficient Inhibition of Avian and Seasonal Influenza A Viruses by a Virus-Specific Dicer-Substrate Small Interfering RNA Swarm in Human Monocyte-Derived Macrophages and Dendritic Cells.
    Jiang M; Österlund P; Westenius V; Guo D; Poranen MM; Bamford DH; Julkunen I
    J Virol; 2019 Feb; 93(4):. PubMed ID: 30463970
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cell culture-based production of defective interfering influenza A virus particles in perfusion mode using an alternating tangential flow filtration system.
    Hein MD; Chawla A; Cattaneo M; Kupke SY; Genzel Y; Reichl U
    Appl Microbiol Biotechnol; 2021 Oct; 105(19):7251-7264. PubMed ID: 34519855
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Generation of a purely clonal defective interfering influenza virus.
    Yamagata Y; Muramoto Y; Miyamoto S; Shindo K; Nakano M; Noda T
    Microbiol Immunol; 2019 May; 63(5):164-171. PubMed ID: 30997933
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Production of antiviral "OP7 chimera" defective interfering particles free of infectious virus.
    Pelz L; Dogra T; Marichal-Gallardo P; Hein MD; Hemissi G; Kupke SY; Genzel Y; Reichl U
    Appl Microbiol Biotechnol; 2024 Dec; 108(1):97. PubMed ID: 38229300
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Defective Interfering Particles of Influenza Virus and Their Characteristics, Impacts, and Use in Vaccines and Antiviral Strategies: A Systematic Review.
    Wu M; Zhou E; Sheng R; Fu X; Li J; Jiang C; Su W
    Viruses; 2022 Dec; 14(12):. PubMed ID: 36560777
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sustained Replication of Synthetic Canine Distemper Virus Defective Genomes
    Tilston-Lunel NL; Welch SR; Nambulli S; de Vries RD; Ho GW; Wentworth DE; Shabman R; Nichol ST; Spiropoulou CF; de Swart RL; Rennick LJ; Duprex WP
    mSphere; 2021 Oct; 6(5):e0053721. PubMed ID: 34550005
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.